Yeongrin Kim - Search Results

Year	Number of Results
2020	2
2021	4
2022	2
2023	3
2024	0

1

Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line.

Kang CH, Kim Y, Lee HK, Lee SM, Jeong HG, Choi SU, Park CH. Kang CH, et al. Among authors: kim y. Int J Mol Sci. 2020 Dec 1;21(23):9163. doi: 10.3390/ijms21239163. Int J Mol Sci. 2020. PMID: 33271901 Free PMC article.

2

Development of Genetically Engineered Feeder Cells for Natural Killer Cell Expansion.

Lee DY, Kim Y, Park JS, Choi JU, Jeong HG, Park CH. Lee DY, et al. Among authors: kim y. Anticancer Res. 2023 Sep;43(9):3897-3904. doi: 10.21873/anticanres.16577. Anticancer Res. 2023. PMID: 37648291

3

Optimized conditions for gene transduction into primary immune cells using viral vectors.

Kim Y, Lee DY, Choi JU, Park JS, Lee SM, Kang CH, Park CH. Kim Y, et al. Sci Rep. 2023 Jul 31;13(1):12365. doi: 10.1038/s41598-023-39597-2. Sci Rep. 2023. PMID: 37524755 Free PMC article.

4

Discovery of BET specific bromodomain inhibitors with a novel scaffold.

Pandit N, Yoo M, Hyun Park T, Kim J, Mi Kim S, Myung Lee K, Kim Y, Min Bong S, Il Lee B, Jung KY, Hoon Park C. Pandit N, et al. Among authors: kim y. Bioorg Med Chem. 2022 Oct 15;72:116967. doi: 10.1016/j.bmc.2022.116967. Epub 2022 Aug 23. Bioorg Med Chem. 2022. PMID: 36099719

5

Development of Antigen-specific Chimeric Antigen Receptor KHYG-1 Cells for Glioblastoma.

Kang CH, Kim Y, Lee SM, Choi SU, Park CH. Kang CH, et al. Among authors: kim y. Anticancer Res. 2021 Apr;41(4):1811-1819. doi: 10.21873/anticanres.14947. Anticancer Res. 2021. PMID: 33813386

6

Novel brd4 inhibitors with a unique scaffold exhibit antitumor effects.

Kim YH, Kim M, Kim JE, Yoo M, Lee HK, Lee CO, Yoo M, Jung KY, Kim Y, Choi SU, Park CH. Kim YH, et al. Among authors: kim y. Oncol Lett. 2021 Jun;21(6):473. doi: 10.3892/ol.2021.12734. Epub 2021 Apr 14. Oncol Lett. 2021. PMID: 33907583 Free PMC article.

7

Structure-activity relationship analysis of novel GSPT1 degraders based on benzotriazinone scaffold and its antitumor effect on xenograft mouse model.

Takwale AD, Kim EY, Jang Y, Lee DH, Kim S, Choi Y, Kim JH, Lee DY, Kim Y, Lee SM, Lee HK, Nam HJ, Lee JY, Cho JH, Moon JH, Lee GS, Kim JH, Kim P, Park CH, Hwang JY. Takwale AD, et al. Among authors: kim y. Bioorg Chem. 2022 Oct;127:105923. doi: 10.1016/j.bioorg.2022.105923. Epub 2022 Jun 13. Bioorg Chem. 2022. PMID: 35717803 Free article.

8

T Cells Expressing CAR Equipped With Extracellular Domain of BTLA Are Effective Against HVEM-over-expressing Melanoma Cell Lines.

Kim Y, Kim JE, Lee DY, Choi JU, Park JS, Lee HK, Choi SU, Park S, Park CH. Kim Y, et al. Anticancer Res. 2023 Aug;43(8):3419-3427. doi: 10.21873/anticanres.16517. Anticancer Res. 2023. PMID: 37500142

9

Synthesis and Structure-Activity Relationships of Aristoyagonine Derivatives as Brd4 Bromodomain Inhibitors with X-ray Co-Crystal Research.

Yoo M, Park TH, Yoo M, Kim Y, Lee JY, Lee KM, Ryu SE, Lee BI, Jung KY, Park CH. Yoo M, et al. Among authors: kim y. Molecules. 2021 Mar 17;26(6):1686. doi: 10.3390/molecules26061686. Molecules. 2021. PMID: 33802888 Free PMC article.

10

c-Met-Specific Chimeric Antigen Receptor T Cells Demonstrate Anti-Tumor Effect in c-Met Positive Gastric Cancer.

Kang CH, Kim Y, Lee DY, Choi SU, Lee HK, Park CH. Kang CH, et al. Among authors: kim y. Cancers (Basel). 2021 Nov 16;13(22):5738. doi: 10.3390/cancers13225738. Cancers (Basel). 2021. PMID: 34830894 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year